Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Batten

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1972
The synthesis of some 32-functionalised lanostane derivativesP L Batten, T J Bentley, R B Boar, et al.
Human & Experimental Toxicology|January 1, 1991
Oral pharmacokinetics of fluazifop-butyl in human volunteersB H Woollen, T B Hart, P L Batten, et al.
Contact Dermatitis|March 1, 1994
Contact dermatitis from the old formula E45 creamT L Batten, R A Wakeel, W S Douglas, et al.
Developments in Toxicology and Environmental Science|January 1, 1983
The disposition of 14C-di-2-ethylhexylphthalate (DEHP) in the marmosetC Rhodes, C R Elcombe, P L Batten, et al.
Environmental Health Perspectives|March 1, 1986
Comparative pharmacokinetics and subacute toxicity of di(2-ethylhexyl) phthalate (DEHP) in rats and marmosets: extrapolation of effects in rodents to manC Rhodes, T C Orton, I S Pratt, et al.
European Journal of Immunology|August 15, 2006
Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cellsCarrie A Fletcher, Andrew P R Sutherland, Joanna R Groom, et al.
Stem Cells (Dayton, Ohio)|August 27, 2005
X-inactivation status varies in human embryonic stem cell linesLisa M Hoffman, Lisa Hall, Jennifer L Batten, et al.
Cancer Gene Therapy|September 7, 2000
Antitumoral effect of a nonviral interleukin-2 gene therapy is enhanced by combination with 5-fluorouracilJ S Bishop, N M Thull, M Matar, et al.
International Journal of Cancer|October 7, 1998
CFTR deltaF508 carrier status, risk of breast cancer before the age of 40 and histological grading in a population-based case-control studyM C Southey, L Batten, C R Andersen, et al.
Haematology and Blood Transfusion|January 1, 1987
Ablative therapy supported by autologous bone marrow transplantation with in vitro treatment of marrow in patients with B-cell malignancyA Z Rohatiner, M J Barnett, S Arnott, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1972
The synthesis of some 32-functionalised lanostane derivativesP L Batten, T J Bentley, R B Boar, et al.
Human & Experimental Toxicology|January 1, 1991
Oral pharmacokinetics of fluazifop-butyl in human volunteersB H Woollen, T B Hart, P L Batten, et al.
Contact Dermatitis|March 1, 1994
Contact dermatitis from the old formula E45 creamT L Batten, R A Wakeel, W S Douglas, et al.
Developments in Toxicology and Environmental Science|January 1, 1983
The disposition of 14C-di-2-ethylhexylphthalate (DEHP) in the marmosetC Rhodes, C R Elcombe, P L Batten, et al.
Environmental Health Perspectives|March 1, 1986
Comparative pharmacokinetics and subacute toxicity of di(2-ethylhexyl) phthalate (DEHP) in rats and marmosets: extrapolation of effects in rodents to manC Rhodes, T C Orton, I S Pratt, et al.
European Journal of Immunology|August 15, 2006
Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cellsCarrie A Fletcher, Andrew P R Sutherland, Joanna R Groom, et al.
Stem Cells (Dayton, Ohio)|August 27, 2005
X-inactivation status varies in human embryonic stem cell linesLisa M Hoffman, Lisa Hall, Jennifer L Batten, et al.
Cancer Gene Therapy|September 7, 2000
Antitumoral effect of a nonviral interleukin-2 gene therapy is enhanced by combination with 5-fluorouracilJ S Bishop, N M Thull, M Matar, et al.
International Journal of Cancer|October 7, 1998
CFTR deltaF508 carrier status, risk of breast cancer before the age of 40 and histological grading in a population-based case-control studyM C Southey, L Batten, C R Andersen, et al.
Haematology and Blood Transfusion|January 1, 1987
Ablative therapy supported by autologous bone marrow transplantation with in vitro treatment of marrow in patients with B-cell malignancyA Z Rohatiner, M J Barnett, S Arnott, et al.
Pageof 7